CYNATA THERAPEUTICSCYNATA THERAPEUTICSCYNATA THERAPEUTICS

CYNATA THERAPEUTICS

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪31.35 M‬EUR
−0.034EUR
‪−6.06 M‬EUR
0.00EUR
‪200.63 M‬
Beta (1Y)
−0.76

About CYNATA THERAPEUTICS LIMITED


CEO
Kilian Kelly
Website
Headquarters
Cremorne
Founded
2003
ISIN
AU000000CYP7
FIGI
BBG000V1V0X1
Cynata Therapeutics Ltd. engages in the development and commercialization of therapeutic products. It focuses on proprietary mesenchymal stem cell technology. The company was founded on March 12, 2003 and is headquartered in Carlton, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CYNATA THERAPEUTICS stocks are traded under the ticker 51S.
We've gathered analysts' opinions on CYNATA THERAPEUTICS future price: according to them, 51S price has a max estimate of 0.50 EUR and a min estimate of 0.40 EUR. Watch 51S chart and read a more detailed CYNATA THERAPEUTICS stock forecast: see what analysts think of CYNATA THERAPEUTICS and suggest that you do with its stocks.
51S reached its all-time high on Mar 15, 2019 with the price of 1.147 EUR, and its all-time low was 0.048 EUR and was reached on Jul 3, 2023. View more price dynamics on 51S chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track CYNATA THERAPEUTICS financials in yearly and quarterly reports right on TradingView.
CYNATA THERAPEUTICS is going to release the next earnings report on Sep 1, 2025. Keep track of upcoming events with our Earnings Calendar.
51S net income for the last half-year is ‪−3.24 M‬ EUR, while the previous report showed ‪−2.80 M‬ EUR of net income which accounts for −15.62% change. Track more CYNATA THERAPEUTICS financial stats to get the full picture.
No, 51S doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 51S shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CYNATA THERAPEUTICS stock right from TradingView charts — choose your broker and connect to your account.